CLINICAL_TRIALS
trial_result
· 2014-05-01
Clinical Trial Update: 4 Weeks Treatment of Type II Diabetic Patients With BI 44847 [Phase 1]
Summary
A Phase 1 trial evaluating four weeks of BI-44847 in adults with Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED